{"artifact":{"id":"experiment-exp-b16b95d5-c9e4-4975-a607-55fcbff7bff7","artifact_type":"experiment","entity_ids":"[\"ACE2, TMPRSS2, FCGRT\"]","title":"Development and validation of triple knock-in humanized mice","quality_score":0.9,"created_by":"experiment_extractor","provenance_chain":"[]","content_hash":"4dec4495c29a3febf8eb50d83f34a8e10812777e8dcb452451462c31f1947079","metadata":{"_origin":{"url":null,"type":"internal","tracked_at":"2026-04-10T03:39:55.419330"},"p_value":null,"protocol":"Generation of triple knock-in mice through genetic engineering to express human versions of ACE2 (viral entry receptor), TMPRSS2 (viral entry protease), and FCGRT (neonatal Fc receptor)","effect_size":null,"sample_size":null,"source_pmid":"40020261","extracted_at":"2026-04-09T20:39:55.416840","_schema_version":1,"experiment_type":"animal_model","success_criteria":"Ability of mice to support viral infection and demonstrate physiologically relevant antibody half-life extension","expected_outcomes":"Mice that can support SARS-CoV-2 infection and accurately model human antibody pharmacokinetics and protective immunity","statistical_methods":null},"created_at":"2026-04-10T03:39:55-07:00","updated_at":"2026-04-10T03:39:55-07:00","version_number":4,"parent_version_id":null,"version_tag":null,"changelog":null,"is_latest":1,"lifecycle_state":"active","superseded_by":null,"deprecated_at":null,"deprecated_reason":null,"dependencies":null,"market_price":0.5,"origin_type":"internal","origin_url":null,"lifecycle_changed_at":"2026-04-10T03:39:55-07:00","citation_count":0,"embed_count":0,"derivation_count":0,"support_count":0,"contradiction_count":0,"total_usage":0.0,"usage_score":0.5,"usage_computed_at":null,"quality_status":"ok","contributors":[],"answers_question_ids":null,"deprecated_reason_detail":null,"deprecated_reason_code":null,"commit_sha":null,"commit_submodule":null,"last_mutated_at":"2026-05-16T14:51:34.657673-07:00","disputed_at":null,"gap_id":null,"mission_id":null,"intrinsic_priority":null,"effective_priority":null,"artifact_id":"13e7602c-2ca6-4148-8eb8-17c16860ef32","artifact_dir":null,"primary_filename":null,"accessory_filenames":null,"folder_layout_version":1,"migrated_to_folder_at":null,"hypothesis_id":null,"authorship":{"kind":"human","contributors":[{"role":"author","actor_ref":"experiment_extractor"}]},"epistemic_tier":"T3_provisional","created_by_agent_id":null},"outgoing_links":[{"target_artifact_id":"wiki-genes-fcgrt","link_type":"related","strength":0.63,"evidence":"Reverse: Gene mention: FCGRT"},{"target_artifact_id":"wiki-genes-fcgrt","link_type":"mentions","strength":0.5,"evidence":"Entity FCGRT in experiment"},{"target_artifact_id":"paper-40020261","link_type":"derives_from","strength":1.0,"evidence":"Extracted from paper abstract/full text"}],"incoming_links":[{"source_artifact_id":"wiki-genes-fcgrt","link_type":"mentions","strength":0.7,"evidence":"Gene mention: FCGRT"},{"source_artifact_id":"wiki-therapeutics-mas-receptor-agonists","link_type":"mentions","strength":0.5,"evidence":"Content: ACE2 mentioned 21x in wiki/therapeutics-mas-receptor-agonists"},{"source_artifact_id":"wiki-hypotheses-post-acute-viral-reservoir-parkinsons","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: ACE2 mentioned 2x in wiki/hypotheses-post-acute-viral-reservoir-parkinsons"},{"source_artifact_id":"wiki-cell-types-spinal-nerve-piriform-plexus","link_type":"mentions","strength":0.5,"evidence":"Content: FCGRT mentioned 4x in wiki/cell-types-spinal-nerve-piriform-plexus"},{"source_artifact_id":"wiki-mechanisms-renin-angiotensin-system","link_type":"mentions","strength":0.5,"evidence":"Content: ACE2 mentioned 18x in wiki/mechanisms-renin-angiotensin-system"},{"source_artifact_id":"wiki-mechanisms-viral-post-infectious-als","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: ACE2 mentioned 2x in wiki/mechanisms-viral-post-infectious-als"},{"source_artifact_id":"wiki-diseases-cidp","link_type":"mentions","strength":0.5,"evidence":"Content: FCGRT mentioned 3x in wiki/diseases-cidp"},{"source_artifact_id":"open_question-83a45555-71de-49c1-9841-2996641b40b5","link_type":"discriminating_experiment","strength":0.85,"evidence":"{\"confidence\": 0.85, \"judge_persona\": \"domain-expert\", \"model\": \"all-MiniLM-L6-v2\"}"}],"current_artifact_id":"experiment-exp-b16b95d5-c9e4-4975-a607-55fcbff7bff7","is_canonical":true,"supersede_chain":["experiment-exp-b16b95d5-c9e4-4975-a607-55fcbff7bff7"]}